TCG Advisory Services LLC Takes $268,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

TCG Advisory Services LLC acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 1,974 shares of the financial services provider’s stock, valued at approximately $268,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp grew its stake in iShares Biotechnology ETF by 3.5% in the third quarter. Bank of New York Mellon Corp now owns 21,146 shares of the financial services provider’s stock worth $2,586,000 after purchasing an additional 716 shares in the last quarter. Macroview Investment Management LLC grew its holdings in shares of iShares Biotechnology ETF by 5,340.0% during the third quarter. Macroview Investment Management LLC now owns 544 shares of the financial services provider’s stock valued at $67,000 after buying an additional 534 shares during the last quarter. Park Avenue Securities LLC acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $238,000. CENTRAL TRUST Co increased its holdings in shares of iShares Biotechnology ETF by 1.2% in the third quarter. CENTRAL TRUST Co now owns 14,838 shares of the financial services provider’s stock valued at $1,815,000 after purchasing an additional 174 shares during the period. Finally, Whittier Trust Co. boosted its position in iShares Biotechnology ETF by 26.4% in the third quarter. Whittier Trust Co. now owns 6,471 shares of the financial services provider’s stock valued at $791,000 after buying an additional 1,350 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB traded down $0.66 during trading on Monday, hitting $132.30. 793,469 shares of the stock traded hands, compared to its average volume of 1,788,422. The company has a fifty day moving average price of $133.61 and a two-hundred day moving average price of $130.12. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.